Power Law company profile

Spark Therapeutics

Biotech & Life Sciences · Philadelphia, United States · Founded 2013 · IPO 2015 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$4.30B

Market cap · 2026

Investors

2 investors on Spark Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

The Children's Hospital of Philadelphia

Series B+ 1 investor entered at this stage

Sofinnova Investments

Global footprint

Where Spark Therapeutics has talent and traffic

AI talent share

0.7% of workforce is AI talent
(2 of 304 staff)

Core AI20.66%

Other AI00%

Non-AI workforce30299.34%

Web traffic by country

2.6K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$50M patent portfolio · 47 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$50M

1.2% of market cap · 40.3× smaller than top peer Ablynx ($2B)

47 active patent families

Where Spark Therapeutics innovates Molecular biologyVirusViral vectorBioinformaticsAdeno-associated virus

Below peer median on Legal, Market

Quality vs same-sector peers

Spark Therapeutics on the five Patsnap quality dimensions

Spark Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Spark Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Spark Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Spark Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo